Patients in UK to be given early access to Sanofi’s eczema treatment
March 14, 2017Research and Development, Sales and Marketing Dupilumab, MHRA, Sanofi
Sanofi’s treatment for atopic dermatitis, otherwise known as eczema, has been given a positive scientific opinion through the MHRA’s Early …
Novartis secures first-line FDA approval in breast cancer indication
March 14, 2017Manufacturing and Production, Sales and Marketing Kisqali, Novartis, breast cancer
The FDA has approved Kisqali (ribociclib) in combination with letrozole for the first-line treatment of postmenopausal women with hormone receptor …
Survivors of Hodgkin lymphoma over twice as likely to suffer second cancer
March 14, 2017Manufacturing and Production, Research and Development Hodgkin lymphoma, ICR
New research emerging from the Institute for Cancer Research (ICR) has found that those previously treated for Hodgkin lymphoma are …
FDA lifts block on Sun Pharma facility
March 14, 2017Manufacturing and Production FDA, Sun Pharma
Sun Pharma has announced that the FDA informed it that the Import Alert in place upon its Mohali manufacturing facility …
One in five women with breast cancer could benefit from existing therapy
March 14, 2017Manufacturing and Production, Research and Development Wellcome Trust Sanger Institute, breast cancer, parp inhibitors
A new study emerging from the Wellcome Trust Sanger Institute has discovered that there are more cases of breast cancer …
XTuit Pharmaceuticals move to appoint biotech veteran as CEO
March 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing XTuit Pharmaceuticals
XTuit Pharmaceuticals has revealed the appointment of Deborah Dunshire as its new President and CEO. XTuit Pharmaceuticals is a biotech …
Mylan’s pathway to launch of biosimilar to Herceptin cleared by Roche
March 13, 2017Manufacturing and Production, Sales and Marketing Genentech, Herceptin, Mylan, Roche, biosimilar
Mylan scored a big victory in its plan to launch its biosimilar to Roche’s blockbuster, Herceptin, after Roche and itself …
Immunotherapy: The three major treatments that are changing cancer prognoses
March 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Cancer, MSD, Roche, immunotherapy, keytruda, oncology, opdivo, tecentriq
The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space. However, …
Combination immunotherapy shows promise in castration-resistant prostate cancer
March 13, 2017Research and Development, Sales and Marketing prostate cancer
Researchers at the University of Texas MD Anderson Cancer Center have found that castration-resistant prostate cancer responds well to a …
Bad start to month for Karyopharm gets worse with clinical hold
March 13, 2017Sales and Marketing Karyopharm
Coming just over a week after Karyopharm Therapeutics had announced that its lead drug had failed in a Phase 2 …
Pfizer announces partnership with UK university
March 13, 2017Medical Communications, Sales and Marketing Pfizer, Swansea University
Pfizer and Swansea University have announced plans to collaborate on a new Innovation Hub at Swansea University’s new £450 million …
Trump makes choice on new FDA head
March 13, 2017Medical Communications, Sales and Marketing FDA, Gottlieb, Trump
Dr. Scott Gottlieb is Trump’s chosen nominee for the role of commissioner of the FDA. The nomination appeases fears within …
TiGenix announces success of novel heart attack stem cell trial
March 13, 2017Research and Development, Sales and Marketing Stem cells, TiGenix, heart attack
Belgium’s TiGenix has announced the success of its top-line Phase 2/3 study investigating the effects of donor-derived expanded cardiac stem …
Oxford BioDynamics installs new SVP of Commercial Development
March 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford BioDynamics
Oxford BioDynamics, a biotech focused on the discovery and development of novel epigenetics biomarkers, has announced the appointment of Martin …
Researchers find common protein link between cancer and autism
March 10, 2017Medical Communications Cancer, SHANK, University of Turku, autism
Researchers from the University of Turku, in Finland, have discovered that there is a common protein, named SHANK, that is …
Top Ten most popular articles on Pharmafile.com this week
March 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
The past week in the industry has brought much hope for patients with the news of significant research data developments …
Breakthrough discovery could lead to new targeted cancer treatment
March 10, 2017Medical Communications Cancer, The Scripps Research Institute
Research conducted by The Scripps Research Institute has unearthed a potential treatment for those with prostate and breast cancer that …
Closure of Scottish J&J plant threatens 400 staff
March 10, 2017Manufacturing and Production, Medical Communications J&J, JJ, Johnson & Johnson
Johnson & Johnson has announced its intention to shut down its surgical suture manufacturing facility in Livingston, Scotland which sees …
Patient engagement is key to building a biosimilar market
March 10, 2017Medical Communications Clarivate analytics, biosimilars
There’s a whole lot of explaining to do before many U.S. patients and doctors will feel comfortable with biosimilars in …
Amgen accuses biosimilar producer of ‘massive conspiracy’
March 9, 2017Medical Communications Amgen, Coherus, Neulasta, biosimilars
Amgen has filed a lawsuit in a Californian state court against Coherus Biosciences, suggesting that Coherus had stolen trade secrets. …
